Summary: New research sheds light on how ketamine affects the brain by targeting a specific NMDA receptor subtype, GluN1-2B-2D. Scientists used electron cryo-microscopy to capture how ketamine binds to this…
Tag: psychopharmacology
Prozac Shows Promise in Fighting Infections & Sepsis
Summary: New research suggests that fluoxetine, commonly used as an antidepressant, may also help protect against infections and sepsis. Scientists found that the drug has antimicrobial properties and helps regulate…
Ketamine Reduces “Giving Up” by Targeting Brain Support Cells
Summary: Researchers have found that ketamine’s antidepressant effects target astroglia, a type of brain support cell, rather than neurons, challenging conventional views. Using zebrafish, scientists observed that ketamine suppressed the…
Can Cannabis Help ADHD? – Neuroscience News
Summary: Researchers are investigating how cannabis affects ADHD symptoms, focusing on its interactions with the body’s endocannabinoid system. Evidence suggests cannabis influences attention, hyperactivity, and anxiety, but the findings are…
Schizophrenia Risks Tied to Psychedelic Use
Summary: A new study links hallucinogen-related emergency department visits to a 21-fold increased risk of schizophrenia compared to the general population. Even after accounting for other mental health disorders and…
Psychedelics Reduce Anxiety Without Hallucinations
Summary: New research has pinpointed the specific brain region and neuron type responsible for reducing anxiety using the psychedelic drug DOI, without triggering hallucinations. The study revealed that DOI targets…
High Doses of ADHD Meds Linked to Increased Psychosis Risk
Summary: Adults taking high doses of amphetamine-based medications for ADHD, such as Adderall, face a five-fold increased risk of developing psychosis or mania. The risk was highest for those taking…
Knowingly Taking Placebos Reduces Stress and Anxiety
Summary: Researchers have discovered that nondeceptive placebos—placebos given with the full knowledge that they are placebos—can effectively manage stress, even when administered remotely. In a two-week randomized controlled trial, participants…
High-Dose Psilocybin Shows Potential as an Antidepressant Treatment
Summary: A meta-analysis suggests that high doses of psilocybin may alleviate depressive symptoms similarly to the SSRI drug escitalopram. While the effect size was small, psilocybin outperformed placebo in clinical…
Cannabigerol (CBG) Reduces Anxiety and Improves Memory
Summary: A new study shows that Cannabigerol (CBG) significantly reduces anxiety without the intoxicating effects of THC. The clinical trial found that 20 mg of CBG reduced anxiety and stress…
